罕见病的临床试验
总计381742个结果
-
Novartis Pharmaceuticals主动,不招人移植物抗宿主病日本, 斯洛伐克, 台湾, 西班牙, 大韩民国, 泰国, 加拿大, 俄罗斯联邦, 意大利, 火鸡, 印度, 捷克语, 巴西, 瑞士
-
Massachusetts Eye and Ear InfirmaryOcular Therapeutix, Inc.撤销
-
Dana-Farber Cancer InstituteBiogen完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)完全的
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.完全的
-
Dana-Farber Cancer Institute完全的
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.终止
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
University of Michigan完全的
-
National Cheng-Kung University Hospital完全的
-
Assistance Publique Hopitaux De Marseille完全的
-
University of Pisa尚未招聘结缔组织病 | 罕见病 | 风湿病
-
Riphah International University完全的
-
University of FloridaFood and Drug Administration (FDA); FDA Office of Orphan Products Development完全的
-
Peking University People's HospitalSun Yat-sen University; Third Military Medical University; Southern Medical University, China完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey完全的
-
Astellas Pharma Korea, Inc.完全的
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)未知移植物抗宿主病
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)撤销
-
Roswell Park Cancer Institute完全的